Literature DB >> 16573308

Primary prevention of type-2 diabetes in developing countries.

Samuel Dagogo-Jack1.   

Abstract

Although diabetes is now a worldwide epidemic, the rate of increase in its prevalence in developing countries is alarming. By the year 2025, more than three-quarters of all persons with diabetes will reside in developing countries. India and China are leading this surge in diabetes, and sub-Saharan Africa is currently at a lower prevalence rate. However, the estimated increase is substantial among African descendants in the Americas, West Indies and throughout the diaspora. There are compelling reasons why aggressive efforts must be directed toward primary prevention of diabetes in developing countries. Once diabetes develops, the cost of caring for patients is prohibitive. Poorly managed diabetes leads to several complications (e.g., end-stage renal failure, blindness, amputation and heart disease) that many developing countries are ill equipped to tackle. In landmark trials, lifestyle modification approaches are more efficacious than expensive medications in the prevention of diabetes. This is fortunate because lifestyle modification can be implemented locally, whereas medications often need to be imported at high cost. The first task is the education of policymakers on the urgent need for timely action to prevent the looming epidemic of diabetes. Once governments become convinced of its critical value, the translation of diabetes prevention through dietary modification and increased physical activity would require careful planning, extensive piloting and creativity in the allocation of scant resources. External support, foreign aid, debt forgiveness and other forms of creative financing will almost certainly be needed to implement widespread diabetes prevention programs in developing countries.

Entities:  

Mesh:

Year:  2006        PMID: 16573308      PMCID: PMC2576111     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  17 in total

1.  Early programming of adult diseases in resource poor countries.

Authors:  A M Prentice; S E Moore
Journal:  Arch Dis Child       Date:  2005-04       Impact factor: 3.791

2.  Standardized comparison of glucose intolerance in west African-origin populations of rural and urban Cameroon, Jamaica, and Caribbean migrants to Britain.

Authors:  J C Mbanya; J K Cruickshank; T Forrester; B Balkau; J Y Ngogang; L Riste; A Forhan; N M Anderson; F Bennett; R Wilks
Journal:  Diabetes Care       Date:  1999-03       Impact factor: 19.112

Review 3.  Emerging epidemic of type 2 diabetes in youth.

Authors:  A L Rosenbloom; J R Joe; R S Young; W E Winter
Journal:  Diabetes Care       Date:  1999-02       Impact factor: 19.112

Review 4.  Multiple drug targets in the management of type 2 diabetes.

Authors:  M H Moneva; S Dagogo-Jack
Journal:  Curr Drug Targets       Date:  2002-06       Impact factor: 3.465

5.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Authors:  J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

6.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

7.  Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.

Authors:  H King; R E Aubert; W H Herman
Journal:  Diabetes Care       Date:  1998-09       Impact factor: 19.112

Review 8.  Type 2 diabetes mellitus in children and youth: a new epidemic.

Authors:  Francine Ratner Kaufman
Journal:  J Pediatr Endocrinol Metab       Date:  2002-05       Impact factor: 1.634

9.  Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2003-09       Impact factor: 19.112

10.  Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program.

Authors:  William H Hernan; Michael Brandle; Ping Zhang; David F Williamson; Margaret J Matulik; Robert E Ratner; John M Lachin; Michael M Engelgau
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

View more
  13 in total

Review 1.  Principles and practice of nonpharmacological interventions to reduce cardiometabolic risk.

Authors:  Samuel Dagogo-Jack; Nonso Egbuonu; Chimaroke Edeoga
Journal:  Med Princ Pract       Date:  2010-03-29       Impact factor: 1.927

Review 2.  Obesity and type 2 diabetes in Sub-Sahara Africa.

Authors:  Jean Claude Mbanya; Felix K Assah; Jude Saji; Emmanuella N Atanga
Journal:  Curr Diab Rep       Date:  2014-07       Impact factor: 4.810

Review 3.  Preventing diabetes mellitus in developing countries.

Authors:  Justin B Echouffo-Tcheugui; Samuel Dagogo-Jack
Journal:  Nat Rev Endocrinol       Date:  2012-04-10       Impact factor: 43.330

Review 4.  Prediabetes as a therapeutic target.

Authors:  Omid Rad Pour; Samuel Dagogo-Jack
Journal:  Clin Chem       Date:  2010-11-09       Impact factor: 8.327

5.  Diabetes in sub-saharan Africa: kenya, mali, mozambique, Nigeria, South Africa and zambia.

Authors:  Mario Azevedo; Sridevi Alla
Journal:  Int J Diabetes Dev Ctries       Date:  2008-10

Review 6.  International Models of Care that Address the Growing Diabetes Prevalence in Developing Countries.

Authors:  Kavita Singh; Harish Ranjani; Elizabeth Rhodes; Mary Beth Weber
Journal:  Curr Diab Rep       Date:  2016-08       Impact factor: 4.810

Review 7.  Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

Authors:  Raj N Kalaria; Gladys E Maestre; Raul Arizaga; Robert P Friedland; Doug Galasko; Kathleen Hall; José A Luchsinger; Adesola Ogunniyi; Elaine K Perry; Felix Potocnik; Martin Prince; Robert Stewart; Anders Wimo; Zhen-Xin Zhang; Piero Antuono
Journal:  Lancet Neurol       Date:  2008-07-28       Impact factor: 44.182

8.  Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy.

Authors:  Min Zheng; Lin-Li Lv; Jie Ni; Hai-Feng Ni; Qing Li; Kun-Ling Ma; Bi-Cheng Liu
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

9.  "In a situation of rescuing life": meanings given to diabetes symptoms and care-seeking practices among adults in Southeastern Tanzania: a qualitative inquiry.

Authors:  Emmy Metta; Ajay Bailey; Flora Kessy; Eveline Geubbels; Inge Hutter; Hinke Haisma
Journal:  BMC Public Health       Date:  2015-03-07       Impact factor: 3.295

10.  A survey on socioeconomic determinants of diabetes mellitus management in a lower middle income setting.

Authors:  Ambepitiyawaduge Pubudu De Silva; Sudirikku Hennadige Padmal De Silva; Rashan Haniffa; Isurujith Kongala Liyanage; Kosala Saroj Amarasiri Jayasinghe; Prasad Katulanda; Chandrika Neelakanthi Wijeratne; Sumedha Wijeratne; Lalini Chandika Rajapakse
Journal:  Int J Equity Health       Date:  2016-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.